search icon
axnx-img

Axonics modulation technologies inc share price

AXNX
NASDAQ
$0.5925
-$0.12
(-16.55%)
1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Axonics modulation technologies inc analyst forecast

Axonics modulation technologies inc key stock metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$3.63B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
601.72K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.83

About axonics modulation technologies inc, common stock

Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of OAB, UR, and FI. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct sales force and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California. As of November 15, 2024, Axonics, Inc. operates as a subsidiary of Boston Scientific Corporation. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Axonics modulation technologies inc stock returns

Time FrameAXNXSectorS&P500
1-Week Return-0.5%0.12%
1-Month Return-1.14%2.27%
3-Month Return-7.18%3.49%
6-Month Return-14%12.04%
1-Year Return-19.19%17.49%
3-Year Return-98.91%29.34%78.55%
5-Year Return-99.08%33.23%75.83%
10-Year Return-96.04%143.69%265.59%

Axonics modulation technologies inc financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue13.82M111.53M180.29M273.70M366.38M[{"date":"2019-12-31","value":3.77,"profit":true},{"date":"2020-12-31","value":30.44,"profit":true},{"date":"2021-12-31","value":49.21,"profit":true},{"date":"2022-12-31","value":74.7,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue6.49M44.44M64.57M76.04M91.83M[{"date":"2019-12-31","value":7.07,"profit":true},{"date":"2020-12-31","value":48.4,"profit":true},{"date":"2021-12-31","value":70.32,"profit":true},{"date":"2022-12-31","value":82.81,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit7.33M67.09M115.72M197.66M274.55M[{"date":"2019-12-31","value":2.67,"profit":true},{"date":"2020-12-31","value":24.44,"profit":true},{"date":"2021-12-31","value":42.15,"profit":true},{"date":"2022-12-31","value":71.99,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin53.04%60.15%64.18%72.22%74.94%[{"date":"2019-12-31","value":70.78,"profit":true},{"date":"2020-12-31","value":80.27,"profit":true},{"date":"2021-12-31","value":85.65,"profit":true},{"date":"2022-12-31","value":96.37,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses87.93M120.85M183.11M240.05M270.20M[{"date":"2019-12-31","value":32.54,"profit":true},{"date":"2020-12-31","value":44.73,"profit":true},{"date":"2021-12-31","value":67.77,"profit":true},{"date":"2022-12-31","value":88.84,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(80.60M)(53.76M)(67.39M)(42.38M)(26.06M)[{"date":"2019-12-31","value":-8059900000,"profit":false},{"date":"2020-12-31","value":-5376000000,"profit":false},{"date":"2021-12-31","value":-6739400000,"profit":false},{"date":"2022-12-31","value":-4238500000,"profit":false},{"date":"2023-12-31","value":-2605700000,"profit":false}]
Total Non-Operating Income/Expense1.33M(2.27M)(14.86M)5.33M34.06M[{"date":"2019-12-31","value":3.91,"profit":true},{"date":"2020-12-31","value":-6.66,"profit":false},{"date":"2021-12-31","value":-43.64,"profit":false},{"date":"2022-12-31","value":15.65,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(79.93M)(54.91M)(79.28M)(62.32M)(8.74M)[{"date":"2019-12-31","value":-7993400000,"profit":false},{"date":"2020-12-31","value":-5491400000,"profit":false},{"date":"2021-12-31","value":-7928500000,"profit":false},{"date":"2022-12-31","value":-6231600000,"profit":false},{"date":"2023-12-31","value":-874400000,"profit":false}]
Income Taxes1.00K1.00K782.00K(2.62M)(2.66M)[{"date":"2019-12-31","value":0.13,"profit":true},{"date":"2020-12-31","value":0.13,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-334.78,"profit":false},{"date":"2023-12-31","value":-339.64,"profit":false}]
Income After Taxes(79.94M)(54.91M)(80.07M)(59.70M)(6.09M)[{"date":"2019-12-31","value":-7993500000,"profit":false},{"date":"2020-12-31","value":-5491500000,"profit":false},{"date":"2021-12-31","value":-8006700000,"profit":false},{"date":"2022-12-31","value":-5969800000,"profit":false},{"date":"2023-12-31","value":-608800000,"profit":false}]
Income From Continuous Operations(79.94M)(54.91M)(80.07M)(59.70M)(12.00M)[{"date":"2019-12-31","value":-7993500000,"profit":false},{"date":"2020-12-31","value":-5491500000,"profit":false},{"date":"2021-12-31","value":-8006700000,"profit":false},{"date":"2022-12-31","value":-5969800000,"profit":false},{"date":"2023-12-31","value":-1199700000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(79.94M)(54.91M)(80.07M)(59.70M)(6.09M)[{"date":"2019-12-31","value":-7993500000,"profit":false},{"date":"2020-12-31","value":-5491500000,"profit":false},{"date":"2021-12-31","value":-8006700000,"profit":false},{"date":"2022-12-31","value":-5969800000,"profit":false},{"date":"2023-12-31","value":-608800000,"profit":false}]
EPS (Diluted)(2.79)(1.50)(1.77)(1.30)0.18[{"date":"2019-12-31","value":-1550,"profit":false},{"date":"2020-12-31","value":-833.33,"profit":false},{"date":"2021-12-31","value":-983.33,"profit":false},{"date":"2022-12-31","value":-722.22,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Axonics modulation technologies inc ratios

Axonics modulation technologies inc liquidity ratios

These ratios help you determine the liquidity of the company. Higher is better.

AXNX
Cash Ratio 5.36
Current Ratio 8.16
Quick Ratio 6.40

Axonics modulation technologies inc asset efficiency ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

AXNX
ROA (LTM) -0.63%
ROE (LTM) -0.89%

Axonics modulation technologies inc liability ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

AXNX
Debt Ratio Lower is generally better. Negative is bad. 0.14
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.86

Axonics modulation technologies inc valuation ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

AXNX
Trailing PE NM
Forward PE 106.38
P/S (TTM) 8.40
P/B 5.46
Price/FCF NM
EV/R 7.68
EV/Ebitda 381.08

Faqs

What is Axonics Modulation Technologies Inc share price today?

Axonics Modulation Technologies Inc (AXNX) share price today is $0.5925

Can Indians buy Axonics Modulation Technologies Inc shares?

Yes, Indians can buy shares of Axonics Modulation Technologies Inc (AXNX) on Vested. To buy from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AXNX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Axonics Modulation Technologies Inc be purchased?

Yes, you can purchase fractional shares of Axonics Modulation Technologies Inc (AXNX) via the Vested app. You can start investing in Axonics Modulation Technologies Inc (AXNX) with a minimum investment of $1.

How to invest in Axonics Modulation Technologies Inc shares from India?

You can invest in shares of Axonics Modulation Technologies Inc (AXNX) via Vested in three simple steps:

  • Click on Sign Up or Invest in AXNX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Axonics Modulation Technologies Inc shares

What is Axonics Modulation Technologies Inc 52-week high and low stock price?

The 52-week high price of Axonics Modulation Technologies Inc (AXNX) is $. The 52-week low price of Axonics Modulation Technologies Inc (AXNX) is $.

What is Axonics Modulation Technologies Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Axonics Modulation Technologies Inc (AXNX) is

What is Axonics Modulation Technologies Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Axonics Modulation Technologies Inc (AXNX) is 5.46

What is Axonics Modulation Technologies Inc dividend yield?

The dividend yield of Axonics Modulation Technologies Inc (AXNX) is 0.00%

What is the Market Cap of Axonics Modulation Technologies Inc?

The market capitalization of Axonics Modulation Technologies Inc (AXNX) is $3.63B

What is Axonics Modulation Technologies Inc's stock symbol?

The stock symbol (or ticker) of Axonics Modulation Technologies Inc is AXNX

How Can Investors Use Axonics Modulation Technologies Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Axonics Modulation Technologies Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Axonics Modulation Technologies Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Axonics Modulation Technologies Inc shares for Indian investors?

When investing in Axonics Modulation Technologies Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Axonics Modulation Technologies Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Axonics Modulation Technologies Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Axonics Modulation Technologies Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Axonics Modulation Technologies Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top